Investor Overview

Recent Newsmore >
03/16/17ViewRay Reports Fourth Quarter and Full Year 2016 Financial Results
FDA 510(k) Clearance of MRIdian Linac in February Follows Strong 2016 Company Provides 2017 Financial Guidance CLEVELAND, March 16, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2016. Fourth Quarter 2016 Highlights: Total revenue of $16.1 million, up from $4.6 million in Q4 2015 Received 4 new orders for MRIdian Systems, totaling $24.3 million, up from 2 orders totaling $11.3 million in ... 
03/14/17ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2016 Financial Results to be Held on March 16, 2017
CLEVELAND, March 14, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2016 financial results, which will take place on Thursday, March 16, 2017 after market close. ViewRay will hold a conference call on Thursday, March 16, 2017 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. The dial-in numbers are (844) 277-1426 for domestic callers and (336) 525-7129 for international callers. The conference ID numbe... 
02/27/17ViewRay Receives FDA 510(k) Clearance for MRIdian Linac
CLEVELAND, Feb. 27, 2017 /PRNewswire/ -- Announces Fourth Quarter and Full Year 2016 Financial Highlights, including Record Revenue and $133.2 million in Backlog ViewRay, Inc. (Nasdaq: VRAY) announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the MRIdian Linac system, the company's next generation linear accelerator-based MRI-guided radiation therapy system. "FDA clearance of the MRIdian Linac is a transformative milestone f... 
02/22/17ViewRay® to Participate in Upcoming Conferences
CLEVELAND, Feb. 22, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to participate in two upcoming investor conferences. The first conference is the 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference in Snowbird, Utah from February 28, 2017 through March 2, 2017. This conference will allow institutional investors to meet with the Company but does not i... 
Corporate Profile

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first and only MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian® addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian®’s increased target accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who would not previously have been considered radiation therapy candidates. ViewRay believes MRIdian® will significantly improve the safety and efficacy of radiation therapy, leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Featured Items
Download Documentation Investor Presentation
Upcoming Eventsmore >
Stock Quotemore >
VRAY (Common Stock)
Exchange :NASDAQ (US Dollar)
Price :$8.59
Change (%) :0.00 (0.00%)
Volume :0
Data as of 03/29/17 4:00 p.m. ET
Event Calendarmore >
March 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High
Formats:  Excel HTML Adobe PDF Word
Formats:  Excel HTML Adobe PDF Word
Formats:  Excel HTML Adobe PDF Word
Formats:  Excel HTML Adobe PDF Word
Formats:  Excel HTML Adobe PDF Word XBRL
SC 13D/A
Formats:  Excel HTML Adobe PDF Word
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever ViewRay Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed.
Copyright 2015 © ViewRay. All rights reserved